  Particle agglutination assays are widely adapted immunological tests that are
based on antigen-antibody interactions. Antibody-coated microscopic particles
are mixed with a test sample that potentially contains the target antigen, as a
result of which the particles form clusters, with a size that is a function of
the antigen concentration and the reaction time. Here, we present a
quantitative particle agglutination assay that combines mobile lens-free
microscopy and deep learning for rapidly measuring the concentration of a
target analyte; as its proof-of-concept, we demonstrate high-sensitivity
C-reactive protein (hs-CRP) testing using human serum samples. A dual-channel
capillary lateral flow device is designed to host the agglutination reaction
using 4 uL of serum sample with a material cost of 1.79 cents per test. A
mobile lens-free microscope records time-lapsed inline holograms of the lateral
flow device, monitoring the agglutination process over 3 min. These captured
holograms are processed, and at each frame the number and area of the particle
clusters are automatically extracted and fed into shallow neural networks to
predict the CRP concentration. 189 measurements using 88 unique patient serum
samples were utilized to train, validate and blindly test our platform, which
matched the corresponding ground truth concentrations in the hs-CRP range (0-10
ug/mL) with an R2 value of 0.912. This computational sensing platform was also
able to successfully differentiate very high CRP concentrations (e.g., >10-500
ug/mL) from the hs-CRP range. This mobile, cost-effective and quantitative
particle agglutination assay can be useful for various point-of-care sensing
needs and global health related applications.
